Publications of Edgar Meinl

Derfuss, T.; Hohlfeld, R.; Meinl, E.: Intrathecal antibody (IgG) production against human herpesvirus type 6 occurs in about 20% of multiple sclerosis patients and might be linked to a polyspecific B-cell response. Journal of Neurology 252 (8), pp. 968 - 971 (2005)

Farina, C.; Krumbholz, M.; Giese, T.; Hartmann, G.; Aloisi, F.; Meinl, E.: Preferential expression and function of Toll-like receptor 3 in human astrocytes. Journal of Neuroimmunology 159 (1-2), pp. 12 - 19 (2005)

Farina, C.; Weber, M. S.; Meinl, E.; Wekerle, H.; Hohlfeld, R.: Glatiramer acetate in multiple sclerosis: Update on potential mechanisms of action. Lancet Neurology 4 (9), pp. 567 - 575 (2005)

Krumbholz, M.; Specks, U.; Wick, M.; Kalled, S. L.; Jenne, D. E.; Meinl, E.: BAFF is elevated in serum of patients with Wegener's granulomatosis. Journal of Autoimmunity 25 (4), pp. 298 - 302 (2005)

Krumbholz, M.; Theil, D.; Derfuss, T.; Rosenwald, A.; Schrader, F.; Monoranu, C. M.; Kalled, S. L.; Hess, D. M.; Serafini, B.; Aloisi, F. et al.; Wekerle, H.; Hohlfeld, R.; Meinl, E.: BAFF is produced by astrocytes and up-regulated in multiple sclerosis lesions and primary central nervous system lymphoma. Journal of Experimental Medicine 201 (2), pp. 195 - 200 (2005)

Theil, D.; Farina, C.; Meinl, E.: Differential expression of CD150 (SLAM) on monocytes and macrophages in chronic inflammatory contexts: Abundant in Crohn's disease, but not in multiple sclerosis. Journal of Clinical Pathology 58 (1), pp. 110 - 111 (2005)

Vargas-Leal, V.; Bruno, R.; Derfuss, T.; Krumbholz, M.; Hohlfeld, R.; Meinl, E.: Expression and function of glial cell line-derived neurotrophic factor (GDNF) family ligands and their receptors on human immune cells. Journal of Immunology 175 (4), pp. 2301 - 2308 (2005)

Farina, C.; Theil, D.; Semlinger, B.; Hohlfeld, R.; Meinl, E.: Distinct responses of monocytes to Toll-like receptor ligands and inflammatory cytokines. International Immunology 16 (6), pp. 799 - 809 (2004)

Meinl, E.; Voltz, R.: Biomarker in der Therapie der Multiplen Sklerose: Läßt sich der Erfolg bald vorhersagen? MMW-Fortschr. Med. Sonderheft 2, p. 517 - 517 (2004)

Weber, M. S.; Starck, M.; Wagenpfeil, S.; Meinl, E.; Hohlfeld, R.; Farina, C.: Multiple sclerosis: Glatiramer acetate inhibits monocyte reactivity in vitro and in vivo. Brain 127, pp. 1370 - 1378 (2004)

Theil, D.; Derfuss, T.; Paripovic, I.; Herberger, S.; Meinl, E.; Schueler, O.; Strupp, M.; Arbusow, V.; Brandt, T.: Latent herpesvirus infection in human trigeminal ganglia causes chronic immune response. American Journal of Pathology 163 (6), pp. 2179 - 2184 (2003)

Farina, C.; Vargas-Leal, V.; Heydari, N.; Kümpfel, T.; Meinl, E.; Hohlfeld, R.: Treatment with glatiramer acetate induces specific IgG4 antibodies in multiple sclerosis patients. Journal of Neuroimmunology 123 (1-2), pp. 188 - 192 (2002)

Kirchhoff, S.; Sebens, T.; Baumann, S.; Krueger, A.; Zawatzky, R.; Min, L. W.; Meinl, E.; Neipel, F.; Fleckenstein, B.; Krammer, P. H.: Viral IFN-regulatory factors inhibit activation-induced cell death via two positive regulatory IFN-Regulatory factor 1- dependent domains in the CD95 ligand promoter. Journal of Immunology 168 (3), pp. 1226 - 1234 (2002)

Meinl, E.; Hohlfeld, R.: Immunopathogenesis of multiple sclerosis: MBP and beyond. Clinical and Experimental Immunology 128 (3), pp. 395 - 397 (2002)

Daubenberger, C. A.; Nickel, B.; Hübner, B.; Siegler, U.; Meinl, E.; Pluschke, G.: Herpesvirus saimiri transformed T cells and peripheral blood mononuclear cells restimulate identical antigen-specific human T cell clones. Journal of Immunological Methods 254 (1-2), pp. 99 - 108 (2001)

Farina, C.; Bergh, F. T.; Albrecht, H.; Meinl, E.; Yassouridis, A.; Neuhaus, O.; Hohlfeld, R.: Treatment of multiple sclerosis with Copaxone (COP) Elispot assay detects COP-induced interleukin-4 and interferon-gamma response in blood cells. Brain 124, pp. 705 - 719 (2001)

Meinl, E.; Derfuss, T.; Pirzer, R.; Blank, N.; Lengenfelder, D.; Blancher, A.; Le Deist, F.; Fleckenstein, B.; Hivroz, C.: Herpesvirus saimiri replaces ZAP-70 for CD3- and CD2-mediated T cell activation. The Journal of Biological Chemistry 276 (40), pp. 36902 - 36908 (2001)

Meinl, E.; Hohlfeld, R.: T cell transformation with Herpesvirus saimiri: A tool for neuroimmunological research. Journal of Neuroimmunology 103 (1), pp. 1 - 7 (2000)

Meinl, E.; Voltz, R.: Immunpathogenese der Multiplen Sklerose. In: Multiple Sklerose (Ed. Schmidt Hoffmann F., R.M.). Urban & Fischer (accepted)

Derfuss, T.; Meinl, E.: Herpesviral proteins regulating apoptosis. In: VIRAL PROTEINS COUNTERACTING HOST DEFENSES, pp. 257 - 272. SPRINGER-VERLAG BERLIN, BERLIN (2002)